Article Information
History
- April 11, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Shilong Li, PhD1,
- Tomi Jun, MD2,
- Zichen Wang, PhD1,
- Yu-Han Kao, PhD1,
- Emilio Schadt, BS1,
- Maximilian F. Konig, MD3,4,
- Chetan Bettegowda, MD, PhD3,5,
- Joshua T. Vogelstein, PhD6,7,
- Nickolas Papadopoulos, PhD3,8,
- Ramon E. Parsons, MD, PhD2,10,
- Rong Chen, PhD1,9,
- Eric E. Schadt, PhD1,9,
- Li Li, MD1,9,* and
- William K. Oh, MD1,2,10,*
- 1Sema4, Stamford, CT, USA
- 2Division of Hematology & Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- 3Ludwig Center, Lustgarten Laboratory, and the Howard Hughes Medical Institute at The Johns Hopkins Kimmel Cancer Center, Baltimore, MD, USA
- 4Division of Rheumatology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
- 5Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
- 6Department of Biomedical Engineering, Institute for Computational Medicine, The Johns Hopkins University, Baltimore, MD, USA
- 7Department of Biostatistics, The Johns Hopkins Bloomberg School of Public Health at The Johns Hopkins University, Baltimore, MD, USA
- 8Department of Oncology and Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
- 9Department of Genetics and Genomic Sciences, The Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- 10Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- ↵*Corresponding author. E-mail: william.oh{at}sema4.com; li.li{at}sema4.com
Posted April 11, 2021.
COVID-19 outcomes among hospitalized men with or without exposure to alpha-1-adrenergic receptor blocking agents
